Back to Search
RICHARD AUSTIN HAJJAR M.D.
M.D.
Interventional Cardiology Physician
NPI: 1588028138IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
25MA106900(NJ)
Education
OTHER
Class of 2016
Research & Publications (20)
Gene remodeling in type 2 diabetic cardiomyopathy and its phenotypic rescue with SERCA2a.
PMID 19649297·PLoS One·2009
4-observational
Mechanical work and energetic analysis of eccentric cardiac remodeling in a volume overload heart failure in rats.
PMID 19201995·Am J Physiol Heart Circ Physiol·2009
7-preclinical
Inducible expression of active protein phosphatase-1 inhibitor-1 enhances basal cardiac function and protects against ischemia/reperfusion injury.
PMID 19299645·Circ Res·2009
7-preclinical
Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology.
PMID 19481088·J Mol Cell Cardiol·2009
6-review
Determination of NMR cogwheel phase cycle with XML.
PMID 19264457·Solid State Nucl Magn Reson·2009
8-other
Rescue of Ca2+ overload-induced left ventricular dysfunction by targeted ablation of phospholamban.
PMID 19074672·Am J Physiol Heart Circ Physiol·2009
7-preclinical
Concurrent upregulation of endogenous proapoptotic and antiapoptotic factors in failing human hearts.
PMID 19234503·Nat Clin Pract Cardiovasc Med·2009
4-observational
The transcription factor Eya2 prevents pressure overload-induced adverse cardiac remodeling.
PMID 19272299·J Mol Cell Cardiol·2009
7-preclinical
Apolipoprotein E deficiency abrogates insulin resistance in a mouse model of type 2 diabetes mellitus.
PMID 19436992·Diabetologia·2009
7-preclinical
Cardionomics: a new integrative approach for screening cardiotoxicity of drug candidates.
PMID 19442031·Expert Opin Drug Metab Toxicol·2009
6-review
Chronic erythropoietin treatment decreases post-infarct myocardial damage in rats without venous thrombogenic effect.
PMID 18596374·Cardiology·2009
7-preclinical
Calcium upregulation by percutaneous administration of gene therapy in cardiac disease (CUPID Trial), a first-in-human phase 1/2 clinical trial.
PMID 19327618·J Card Fail·2009
3-trial
Long-term cardiac-targeted RNA interference for the treatment of heart failure restores cardiac function and reduces pathological hypertrophy.
PMID 19237664·Circulation·2009
7-preclinical
Prevention of ventricular arrhythmias with sarcoplasmic reticulum Ca2+ ATPase pump overexpression in a porcine model of ischemia reperfusion.
PMID 18645052·Circulation·2008
7-preclinical
Recirculating cardiac delivery of AAV2/1SERCA2a improves myocardial function in an experimental model of heart failure in large animals.
PMID 18650850·Gene Ther·2008
4-observational
Role of resistin in cardiac contractility and hypertrophy.
PMID 18597775·J Mol Cell Cardiol·2008
7-preclinical
Imaging in cardiac cell-based therapy: in vivo tracking of the biological fate of therapeutic cells.
PMID 18641613·Nat Clin Pract Cardiovasc Med·2008
6-review
The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: a potent target for cardiovascular diseases.
PMID 18665137·Nat Clin Pract Cardiovasc Med·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 185 S ORANGE AVE
NEWARK, NJ 07103 - Phone
- (973) 972-4595
Quick Facts
- NPI
- 1588028138
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 10
- Publications
- 20
Are you this provider?
Claim Your Profile